Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report**Supported in part by grant 16842 from the National Institutes of Health, Bethesda, Maryland and in part by Beth Israel Hospital Pathology Foundation, Boston, Massachusetts.-Reference-Cited by-同舟云学术

Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report**Supported in part by grant 16842 from the National Institutes of Health, Bethesda, Maryland and in part by Beth Israel Hospital Pathology Foundation, Boston, Massachusetts.

Published:1996-03 Issue:3 Volume:65 Page:552-555
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Krasnow Joel S.,Berga Sarah L.,Guzick David S.,Zeleznik Anthony J.,Yeo Kiang-Teck

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference13 articles.

1. Ovarian hyperstimulation syndrome: a review of pathophysiology;Bergh;J Assist Reprod Genet,1992

2. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome;Balasch;Ann Intern Med,1994

3. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascher fluid;Senger;Science,1983

4. Molecular and biological properties of the vascular endothelial growth factor family of proteins;Ferrara;Endocr Rev,1992

5. Vascular permeability factor in tumor biology;Senger;Cancer Metastasis Rev,1993

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment;Taiwanese Journal of Obstetrics and Gynecology;2021-09

2. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS);Journal of Ovarian Research;2020-03-05

3. A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL;Current Medical Science;2019-04

4. The Ovarian Hyperstimulation Syndrome;Vitamins and Hormones;2018

5. The effects of formoterol on the serum, peritoneal VEGF, MDA, and VEGF levels in the ovaries and endometrium of rats with OHSS;Clinical and Experimental Obstetrics & Gynecology;2017-02-10